vs
嘉楠科技（CAN）与KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是嘉楠科技的1.1倍（$22.6M vs $20.8M），嘉楠科技净利率更高（-18.4% vs -145.3%，领先126.9%）
嘉楠科技（Canaan Inc.），也以嘉楠耘智之名开展业务，总部位于新加坡，是一家成立于2013年的计算机硬件厂商，由张楠赓创立，核心产品为比特币挖矿专用的区块链服务器与ASIC微处理器，在加密货币挖矿硬件领域拥有深厚技术积累。
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
CAN vs KMTS — 直观对比
营收规模更大
KMTS
是对方的1.1倍
$20.8M
净利率更高
CAN
高出126.9%
-145.3%
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $20.8M | $22.6M |
| 净利润 | $-3.8M | $-32.8M |
| 毛利率 | 99.9% | 50.6% |
| 营业利润率 | -15.9% | -140.7% |
| 净利率 | -18.4% | -145.3% |
| 营收同比 | — | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.05 | $-0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CANKMTS
| Q4 25 | $20.8M | $22.6M | ||
| Q3 25 | $13.8M | $19.4M | ||
| Q2 25 | $11.4M | — | ||
| Q3 24 | $10.2M | — | ||
| Q2 24 | $4.8M | — |
净利润CANKMTS
| Q4 25 | $-3.8M | $-32.8M | ||
| Q3 25 | $-1.5M | $-25.8M | ||
| Q2 25 | $-11.9M | — | ||
| Q3 24 | $-10.4M | — | ||
| Q2 24 | $-5.4M | — |
毛利率CANKMTS
| Q4 25 | 99.9% | 50.6% | ||
| Q3 25 | 99.9% | 45.7% | ||
| Q2 25 | 99.9% | — | ||
| Q3 24 | 99.9% | — | ||
| Q2 24 | 99.8% | — |
营业利润率CANKMTS
| Q4 25 | -15.9% | -140.7% | ||
| Q3 25 | -27.0% | -149.1% | ||
| Q2 25 | -45.5% | — | ||
| Q3 24 | -77.2% | — | ||
| Q2 24 | -193.9% | — |
净利率CANKMTS
| Q4 25 | -18.4% | -145.3% | ||
| Q3 25 | -11.0% | -133.3% | ||
| Q2 25 | -104.4% | — | ||
| Q3 24 | -102.7% | — | ||
| Q2 24 | -112.3% | — |
每股收益（稀释后）CANKMTS
| Q4 25 | $-0.05 | $-0.64 | ||
| Q3 25 | $-0.02 | $-0.50 | ||
| Q2 25 | $-0.25 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $175.4M |
| 总债务越低越好 | $6.2M | — |
| 股东权益账面价值 | $52.4M | $164.1M |
| 总资产 | $92.5M | $246.7M |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资CANKMTS
| Q4 25 | — | $175.4M | ||
| Q3 25 | — | $201.2M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
总债务CANKMTS
| Q4 25 | $6.2M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $6.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CANKMTS
| Q4 25 | $52.4M | $164.1M | ||
| Q3 25 | $44.7M | $184.2M | ||
| Q2 25 | $33.8M | — | ||
| Q3 24 | $43.6M | — | ||
| Q2 24 | $56.8M | — |
总资产CANKMTS
| Q4 25 | $92.5M | $246.7M | ||
| Q3 25 | $81.7M | $266.3M | ||
| Q2 25 | $78.0M | — | ||
| Q3 24 | $69.3M | — | ||
| Q2 24 | $73.7M | — |
负债/权益比CANKMTS
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.18× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-18.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-25.6M |
| 自由现金流率自由现金流/营收 | — | -113.5% |
| 资本支出强度资本支出/营收 | — | 32.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CANKMTS
| Q4 25 | — | $-18.3M | ||
| Q3 25 | — | $-26.3M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流CANKMTS
| Q4 25 | — | $-25.6M | ||
| Q3 25 | — | $-34.4M | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率CANKMTS
| Q4 25 | — | -113.5% | ||
| Q3 25 | — | -177.8% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度CANKMTS
| Q4 25 | — | 32.2% | ||
| Q3 25 | — | 42.2% | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
